ArticleProstate international2025

A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia.

Teak Jun Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.